Literature DB >> 7530869

Renal allograft rejection. Tubular epithelial cells present alloantigen in the presence of costimulatory CD28 antibody.

J L Wilson1, G Proud, J L Forsythe, R M Taylor, J A Kirby.   

Abstract

Renal tubular epithelial cells can be induced to express potentially immunogenic levels of class II MHC antigens but fail to stimulate the activation of allospecific T lymphocytes. The current series of experiments was performed to determine whether the failure of lymphocyte activation in this system is caused by defective T cell costimulation. It was found that cultured renal epithelial cells expressed class II MHC antigens and the immunoregulatory adhesion molecules intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and lymphocyte function-associated antigen-3 after stimulation with IFN-gamma, but that the B7 ligand for CD28 was not expressed. Mixed cell culture experiments were set up in which lymphocytes were mixed with IFN-gamma-treated allogeneic renal cells. Lymphoproliferation and IL-2 production were only observed if bivalent anti-CD28 antibodies were titrated into these cultures. The requirement for antigen stimulation was retained by these lymphocytes, as no proliferation was observed after stimulation by class II MHC antigen nonexpressing, resting renal cells. Further experiments demonstrated that the effectiveness of the anti-CD28 antibody-mediated signal was enhanced by cross-linking with a secondary anti-kappa-chain antibody. These data are consistent with the concept that a costimulatory signal generated by ligation of CD28 is of central importance to the development of an immune response to alloantigen. Furthermore, these results indicate that tubular epithelial cells within a rejecting renal allograft are unlikely to initiate direct activation of infiltrating allospecific lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7530869

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  6 in total

1.  Bladder cancer immunogenicity: expression of CD80 and CD86 is insufficient to allow primary CD4+ T cell activation in vitro.

Authors:  S J Pettit; S Ali; E O'Flaherty; T R Griffiths; D E Neal; J A Kirby
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

2.  Active uptake of dendritic cell-derived exovesicles by epithelial cells induces the release of inflammatory mediators through a TNF-alpha-mediated pathway.

Authors:  Carolina Obregon; Barbara Rothen-Rutishauser; Peter Gerber; Peter Gehr; Laurent P Nicod
Journal:  Am J Pathol       Date:  2009-07-23       Impact factor: 4.307

Review 3.  Immunologic tolerance in renal transplantation.

Authors:  D A Shoskes
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

4.  A comparison of the antigen-presenting capabilities of class II MHC-expressing human lung epithelial and endothelial cells.

Authors:  A C Cunningham; J G Zhang; J V Moy; S Ali; J A Kirby
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

5.  Human renal tubular epithelial cells suppress alloreactive T cell proliferation.

Authors:  M W H J Demmers; S S Korevaar; M Roemeling-van Rhijn; T P P van den Bosch; M J Hoogduijn; M G H Betjes; W Weimar; C C Baan; A T Rowshani
Journal:  Clin Exp Immunol       Date:  2015-03       Impact factor: 4.330

6.  The TreaT-Assay: A Novel Urine-Derived Donor Kidney Cell-Based Assay for Prediction of Kidney Transplantation Outcome.

Authors:  Constantin J Thieme; Benjamin J D Weist; Annemarie Mueskes; Toralf Roch; Ulrik Stervbo; Kamil Rosiewicz; Patrizia Wehler; Maik Stein; Peter Nickel; Andreas Kurtz; Nils Lachmann; Mira Choi; Michael Schmueck-Henneresse; Timm H Westhoff; Petra Reinke; Nina Babel
Journal:  Sci Rep       Date:  2019-12-13       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.